INDUSTRY PROGRAMME

INDUSTRY
PROGRAMME

EULAR 2026 | INDUSTRY PROGRAMME

SATELLITE SYMPOSIA & CONSULT THE EXPERT

A number of Satellite Symposia and Consult the Expert sessions will be organised during EULAR 2026. We invite you to explore our Industry Programme e-booklet (available in May 2026) to discover which ones. Satellite Symposia and Consult the Expert sessions are governed by the EULAR Code of Practice, and are strictly prohibited during the official programme hours. All industry sessions and special events must be approved by EULAR. 

In order to adhere to local and European regulations, primarily concerning prescription rights, participants with a white dot on their EULAR 2026 Congress badge are not permitted to access any industry sessions (Satellite Symposia or Consult the Expert). Exhibitor badges are only valid for entry to the sessions they are organising. Thank you for adhering to the rules.

SCHEDULE OVERVIEW

Available in March 2026.

WEDNESDAY, 3 JUNE 2026
--
--

THURSDAY, 4 JUNE 2026

--
--
--
--

FRIDAY, 5 JUNE 2026

--
--
--
--

SATELLITE SYMPOSIUM PROGRAMME OVERVIEW

Available in March 2026.

CONSULT THE EXPERT PROGRAMME OVERVIEW

​

Available in March 2026.

Available in March 2026.

CONSULT THE EXPERT PROGRAMME OVERVIEW

11 June I 15:45 – 16:15 CEST 

UCB - Motherhood and Systemic Lupus Erythematosus: Navigating the Unknowns​

Session details 

12 June I 09:45 – 10:15 CEST 

AbbVie - ​Your GCA Questions Answered – From Diagnosis to Long-term Care​ 

Session details 

 

12 June I 09:45 – 10:15 CEST 

GSK - ​Act now: The case for early intervention and disease modification in SLE and LN​ 

Session details 

 

12 June I 09:45 – 10:15 CEST 

UCB - ​Cracking the MRI Code in axSpA: How to Get the Right Images for the Right Diagnosis 

Session details 


12 June I 15:00 – 15:30 CEST 

GSK - ​Looking ahead: Connecting the dots in CTD-ILD from immuno-pathophysiology to trial design​ 

Session details 

 

12 June I 15:00 – 15:30 CEST 

Johnson & Johnson - Sharing is caring: practical insights into the challenges of psoriatic arthritis​ 

Session details 

 

12 June I 15:00 – 15:30 CEST 

MSD - Systemic Lupus Erythematosus: Addressing Inflammation, Restoring Homeostasis, and Unveiling Unmet Needs 

Session details 

Available in March 2026.

13 June I 08:15 – 09:30 CEST 

Amgen - DAZzling beyond B cells: Addressing the heterogeneity of Sjögren’s disease 

Session details 

 

13 June I 08:15 – 09:30 CEST 

Boehringer Ingelheim - Perfect Partnerships in Fibrosing Connective Tissue Disease (CTD)-Associated ILDs 

Session details 

 

13 June I 08:15 – 09:30 CEST 

GSK - ​Evolving Expectations in EGPA: Striving for Remission with RWE​ 

Session details 

 

13 June I 08:15 – 09:30 CEST 

Medac - Current trends of methotrexate therapy – do you know it all? 

Session details 

 

13 June I 08:15 – 09:30 CEST 

UCB & Biogen - Shifting the Paradigm Beyond B Cells: Targeting Upstream Immune Drivers in Systemic Lupus Erythematosus 

Session details 

 

13 June I 17:30 – 18:45 CEST 

Sanofi - The Clock is Ticking: When to Break Free from  Glucocorticoids in Polymyalgia Rheumatica? 

Session details 

 

13 June I 17:30 – 18:45 CEST 

Sobi - Putting on your VEXAS goggles: Seeing what’s in plain sight​ 

Session details 

CONSULT THE EXPERT PROGRAMME OVERVIEW

11 June I 15:45 – 16:15 CEST 

UCB - Motherhood and Systemic Lupus Erythematosus: Navigating the Unknowns​

Session details 


12 June I 09:45 – 10:15 CEST 

AbbVie - ​Your GCA Questions Answered – From Diagnosis to Long-term Care​ 

Session details 

 

12 June I 09:45 – 10:15 CEST 

GSK - ​Act now: The case for early intervention and disease modification in SLE and LN​ 

Session details 

 

12 June I 09:45 – 10:15 CEST 

UCB - ​Cracking the MRI Code in axSpA: How to Get the Right Images for the Right Diagnosis 

Session details 


12 June I 15:00 – 15:30 CEST 

GSK - ​Looking ahead: Connecting the dots in CTD-ILD from immuno-pathophysiology to trial design​ 

Session details 

 

12 June I 15:00 – 15:30 CEST 

Johnson & Johnson - Sharing is caring: practical insights into the challenges of psoriatic arthritis​ 

Session details 

 

12 June I 15:00 – 15:30 CEST 

MSD - Systemic Lupus Erythematosus: Addressing Inflammation, Restoring Homeostasis, and  Unveiling Unmet Needs 

Session details 

13 June I 09:45 – 10:15 CEST 

AstraZeneca - Managing SLE across manifestations: ​expert perspectives on preventing organ damage 

Session details 

 

13 June I 09:45 – 10:15 CEST 

BMS - Exploring Sex Differences in Psoriatic Arthritis: Latest Insights and Practical Cases  

Session details 

 

13 June I 09:45 – 10:15 CEST 

Eli Lilly - Pso2PsA: Where are we right now and where should we go?  

Session details 

 

13 June I 15:00 – 15:30 CEST 

Alexion - ​Could It Be Hypophosphatasia (HPP)? A Conversation With Experts​ 

Session details 

 

13 June I 15:00 – 15:30 CEST 

CSL Vifor - Bridging the gaps in ANCA-associated vasculitis care: Expert insights and patient perspectives 

Session details 

 

13 June I 15:00 – 15:30 CEST 

GSK - ​Advancing EGPA care: The evolving IL-5 science​ 

Session details 

 

 Not yet available.


ABSTRACTS